Actemra Tocilizumab regulatory update

FDA's Arthritis Advisory Committee will meet on July 29 to discuss a BLA from Roche for Actemra tocilizumab to treat moderate to severe rheumatoid arthritis (RA) in adults. Roche submitted the BLA l...